Status:
RECRUITING
Lung_Cancer_adaptive - Ethos
Lead Sponsor:
University Hospital, Essen
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In patients with lung carcinoma who receive radiotherapy preoperatively or alternatively curative, high-dose radiotherapy instead of surgery, there are also deformations of the thorax from fraction to...
Detailed Description
With online-adaptive radiotherapy (ART), the radiotherapy plan can be adapted to the anatomical changes before each radiotherapy fraction. The basis for adaptation is a cone-beam CT with the patient o...
Eligibility Criteria
Inclusion
- Patients with NSCLC/SCLC ≥18 years of age in stage III or IV, oligometastatic, for whom the indication for neoadjuvant or definitive radiotherapy/radiotherapy/chemotherapy has been established in the certified lung tumour board.
Exclusion
- Patients who are unable to perform a reproducible breath-hold manoeuvre on inspiration are not included in this study.
Key Trial Info
Start Date :
August 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06222190
Start Date
August 2 2023
End Date
February 1 2025
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Strahlentherapie, Universitätsklinikum Essen
Essen, North Rhine-Westphalia, Germany, 45147